Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 4. |
Subtitle 34. BOARD OF PHARMACY |
Chapter 10.34.35. Infusion Pharmacy Services in an Alternate Site Care Environment |
Sec. 10.34.35.04. Pharmacist Responsibilities
-
A. A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.
B. A pharmacist shall:
(1) Provide infusion therapy services in accordance with:
(a) Orders issued by a licensed authorized prescriber of record; and
(b) Where applicable, protocols issued by a licensed authorized prescriber of record.
(2) Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:
(a) Patient demographics including:
(i) Name;
(ii) Address;
(iii) Telephone number;
(iv) Gender; and
(v) Date of birth;
(b) Emergency contact information;
(c) Diagnoses, including:
(i) Diagnosis being treated; and
(ii) Concurrent conditions, including pregnancy and lactation status if applicable;
(d) Medical history;
(e) Allergies;
(f) If applicable, height;
(g) Weight;
(h) Parenteral medication orders, including length of therapy;
(i) Parenteral infusion access device:
(i) Location;
(ii) Type; and
(iii) If available, date of placement;
(j) Ongoing medication profile review and reconciliation at end of therapy;
(k) First dose status;
(l) Caregiver information including, but not limited to:
(i) Name;
(ii) Address;
(iii) Phone number; and
(iv) Relationship to patient;
(m) If applicable, contact information for other agencies or individuals involved in the patients home care;
(n) Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:
(i) Language;
(ii) Sight;
(iii) Hearing;
(iv) History of IV drug abuse;
(v) History of drug or alcohol abuse; or
(vi) Other physical or mental limitations; and
(o) If applicable to therapy, baseline labs;
(3) Create a patient care plan specific to the patients:
(a) Diagnosis;
(b) Prescribed therapy; and
(c) Concurrent conditions;
(4) When compounding sterile preparations, comply with COMAR 10.34.19;
(5) If sterile compounding is outsourced, comply with COMAR 10.34.04;
(6) As applicable, retrieve and assess lab values and other monitoring parameters;
(7) Document in the patient chart:
(a) New prescription orders;
(b) Changes in prescription orders;
(c) Information obtained from the patient or caregiver; and
(d) Other necessary information obtained from the:
(i) Patient;
(ii) Caregiver;
(iii) Infusion nurse;
(iv) Licensed authorized prescriber of record; or
(v) Other sources relevant to patient care;
(8) Verify prescription label accuracy;
(9) Communicate as appropriate, throughout the patients therapy with the:
(a) Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;
(b) Patients infusion nurse;
(c) Patient; and
(d) Caregiver; and
(10) Review therapy-specific considerations such as pain and nutrition status.